Motor imagery impaired in Parkinson’s patients, study finds
Besides motor challenges, people with Parkinson’s disease have difficulty with motor imagery, or generating a mental representation of a…
Articles by Andrea Lobo
Companies partner on customized Parkinson’s biomarker testing
A new partnership will work to develop customized assays to detect and quantify blood biomarkers to support the advancement of…
Hearing loss may be a big risk factor for Parkinson’s, study says
Hearing loss may be a risk factor for later developing Parkinson’s disease, and the risk may be higher for…
MJFF initiative targets LRRK2 gene biomarkers, therapies
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced an initiative to accelerate the identification of biomarkers and the…
Yale to open new center for advanced research into Parkinson’s
The American Parkinson Disease Association (APDA) is funding a new APDA Center for Advanced Research at Yale University’s School…
Company’s goal: Therapies to clear proteins causing Parkinson’s
Booster Therapeutics announced its launch and the start of work into therapeutics that improve the body’s ability to clear…
MJFF awards second $2.5M grant to Selonterra for Parkinson’s research
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a second research grant of $2.5 million to…
GT-02287 may slow Parkinson’s progression, new early data suggest
Gain Therapeutics has presented new preclinical data showing GT-02287, its experimental therapy for Parkinson’s disease, can slow disease…
NIH grant aids work to diagnose, monitor Parkinson’s via eye’s retina
Researchers at New York University (NYU) Langone Health were awarded a two-year, $1.6 million grant by the National Institutes of…
One year of ND0612 reduced off time, increased good on time
Note: This story was updated Oct. 7, 2024, to correct references to the open-label extension study of the BounDNless trial.